Search

Hutchison China MediTech Ltd ADR

Fechado

SetorSaúde

14.29 0.92

Visão Geral

Variação de preço das ações

24h

Atual

Mín

13.77

Máximo

14.35

Indicadores-chave

By Trading Economics

Rendimento

-8.9M

-8M

Vendas

3.7M

139M

P/E

Médio do Setor

141.8

49.241

Margem de lucro

-5.724

Funcionários

1,790

EBITDA

18M

4M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+27.8% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

553M

2.5B

Abertura anterior

13.37

Fecho anterior

14.29

Hutchison China MediTech Ltd ADR Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

23 de out. de 2026, 23:56 UTC

News

Sherwin-Williams Co declared a quarterly dividend of $0.80 per share, with shares advancing modestly higher in after-market trading.

23 de out. de 2026, 23:56 UTC

News

Hershey Co shares advanced in after-market trading as analysts expect increased earnings and revenue for the September 2026 quarter, driven by brand spending and new product launches.

23 de out. de 2026, 23:51 UTC

News

Jefferies maintains Hold rating on RingCentral and raises price target to $75, reflecting ongoing evaluations of the company's market position and growth potential.

23 de out. de 2026, 23:51 UTC

News

Wix.com Ltd shares are trading lower in after-market hours following a partnership announcement with K Health to integrate its clinical AI assistant into web technology.

23 de out. de 2026, 23:51 UTC

News

Jefferies upgraded MSC Industrial Direct Co to Buy and raised its price target to $135, contributing to the stock's increase in after-market trading.

23 de out. de 2026, 23:41 UTC

News

DA Davidson maintained a Neutral rating on Pool Corp and lowered its price target to $200, contributing to the stock's decline in after-market hours.

23 de out. de 2026, 23:41 UTC

Social Media
News

CME Group Inc is trading modestly higher in after-market hours, following a report of $326.7 billion in Bitcoin derivatives trading volume for Q3.

23 de out. de 2026, 23:21 UTC

News

Pomerantz LLP has filed a class action lawsuit against Papa John's International Inc. over alleged securities fraud and unlawful business practices.

23 de out. de 2026, 23:11 UTC

News

Carriage Services Inc. plans to release its third-quarter earnings on November 4, 2026, followed by a conference call on November 5.

23 de out. de 2026, 23:11 UTC

News
Macro News

Bitcoin declines below $82K as rising interest rates pressure technology stocks; Franklin Templeton registers two Nasdaq ETFs to reinvest stock dividends into Bitcoin.

23 de out. de 2026, 23:11 UTC

News

Telsey Advisory Group maintains Market Perform rating on Deckers Outdoor Corp and lowers price target to $90.

23 de out. de 2026, 23:06 UTC

News

Estee Lauder Companies Inc. is trading lower in after-market hours.

23 de out. de 2026, 23:06 UTC

News

Dow Inc. reported third-quarter 2026 sales of $11.27 billion and net income of $458 million, with shares modestly lower in after-market trading.

23 de out. de 2026, 23:06 UTC

News

Citigroup restricts third-party AI agents from accessing its banking platforms, addressing security concerns shared by major banks like Wells Fargo and JPMorgan Chase.

23 de out. de 2026, 23:06 UTC

News

BlackRock Inc trades roughly flat since Friday's close.

23 de out. de 2026, 23:06 UTC

News

Northrop Grumman awarded a $43.9 million contract by the U.S. Department of Defense for new rocket motor production facilities for the Trident II system.

23 de out. de 2026, 23:06 UTC

News

Valero Energy Corp shares advanced in after-market trading following a significant increase in third-quarter net income and revenue amid rising oil prices.

23 de out. de 2026, 23:01 UTC

News

FuelCell Energy Inc. faces a class action lawsuit from Pomerantz LLP alleging securities fraud linked to claims about manufacturing capacity and production rates.

23 de out. de 2026, 23:01 UTC

News

JetBlue faces negative sentiment as creditors meet with a restructuring adviser amid declining bond and share values, according to The Wall Street Journal.

23 de out. de 2026, 23:01 UTC

News

Uber is reportedly in talks to acquire Instacart, alongside DoorDash, amid increased interest in food delivery sector acquisitions, contributing to after-market gains.

23 de out. de 2026, 23:01 UTC

News

DICK'S Sporting Goods faces a class action lawsuit over securities fraud, following earnings of $3.53 per share and revenue of $1.73 billion, both below expectations.

23 de out. de 2026, 22:56 UTC

News

SS&C Technologies Holdings Inc is trading higher in after-market hours following financial updates that revealed increased revenue, record adjusted EBITDA, and a raised dividend.

23 de out. de 2026, 22:41 UTC

News

MetroCity Bankshares reports Q3 net income of $24.3 million, up from $22.1 million, but total revenue of $47.942 million misses expectations of $51.300 million.

23 de out. de 2026, 21:51 UTC

News

General Mills Inc shares rose in after-market trading following the launch of EPIC Sticks, amid broader market gains and positive U.S. business activity indicators.

23 de out. de 2026, 21:02 UTC

News

Union Pacific Corp's shares declined in after-market trading.

23 de out. de 2026, 21:02 UTC

News
Correlated Moves

USD/PLN is advancing, supported by a stronger U.S. dollar amid rising crude oil prices and inflation expectations following robust U.S. manufacturing data.

23 de out. de 2026, 21:02 UTC

News

The USD/DKK is trading higher, supported by stronger U.S. economic indicators, while Eurozone activity shows signs of weakening, with France's output index declining.

23 de out. de 2026, 21:02 UTC

Correlated Moves
News

USD/CZK is trading modestly higher, supported by U.S. dollar strength amid concerns over weakening Eurozone economic activity and rising inflation expectations.

23 de out. de 2026, 21:01 UTC

News

Illinois Tool Works Inc. is trading modestly higher in after-market hours ahead of its September quarter results, with expected earnings of $2.99 per share.

23 de out. de 2026, 20:13 UTC

News

Ensign Group schedules its Q3 2026 earnings call for October 28, following results on October 27, generating investor interest in after-market trading.

Comparação entre Pares

Variação de preço

Hutchison China MediTech Ltd ADR Previsão

Preço-alvo

By TipRanks

27.8% parte superior

Previsão para 12 meses

Média 18.25 USD  27.8%

Máximo 18.5 USD

Mínimo 18 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Hutchison China MediTech Ltd ADR - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

2

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Hutchison China MediTech Ltd ADR

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors. It also develops Surufatinib, which is used for the treatment of pancreatic neuroendocrine tumor (NET), non-pancreatic NET, neuroendocrine carcinoma, SCLC, biliary tract cancer, and solid tumors; and Sovleplenib that treats hematological cancers and certain chronic immune diseases. In addition, it develops Tazemetostat for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, chondrosarcomas, cholangiocarcinomas, and solid tumors; HMPL-760, a Bruton's tyrosine kinase inhibitor; HMPL-453 for intrahepatic cholangiocarcinoma and solid tumors; HMPL-295 and HMPL-415 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and HMPL-A83 for the treatment of malignant neoplasms. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.
help-icon Live chat